The Weil Institute Pre-Clinical Critical Care Laboratory (PC3L) is collaborating with medical device maker Abiomed, Inc. to examine the potential of using Abiomed Impella CP® left ventricular assist device as a resuscitative strategy for sudden cardiac arrest.
Read MoreMCIRCC’s objective is to transform critical care through innovation, integration, and entrepreneurship. But what does that mean and how is it being done? The MCIRCC Pre-Clinical Operative and Intensive Care Unit was created in February 2013 to embody this objective and has made great strides in high-risk, high-reward pursuits.
Read More